LION Bioscience might become king of summer's IPOs
Article Abstract:
This article describes the rush in Europe to invest in biotechnology companies. While MediGene, GeneScan Europe, Curasan and Modex Therapeutics are among the most popular new companies, LION Bioscience, which plans to issue 4.57 million shares, could be the biggest biotech IPO in Europe this summer.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Germany's bitter ethics debate
Article Abstract:
In Germany, a contentious ethical debate has arisen over the utilization of human embryos in research. The debate is being carried out within the context of Germany's Nazi past and the country's biotechnology future.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Bayer emerges as front-runner for Aventis unit
Article Abstract:
Bayer AG has become the leading contender to acquire Aventis SA's CropScience unit. The unit is valued at approximately $3 billion (3.55 billion euros).
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: J.P. Morgan Chase saw net income decline in quarter. Banks' 2nd-quarter results disappoint. Enron secures $1.5 billion in financing from creditors
- Abstracts: ICI sells some businesses to Huntsman. Colt's agrees to acquire Germany's Heckler & Koch. Tomkins to sell Smith & Wesson to Saf-T-Hammer for $15 million
- Abstracts: Knight Ridder plans reduction of jobs at most papers. USG's shares soar after firm files for protection. CareerBuilder to buy rival site for $200 million
- Abstracts: U.S. rejects linking of plane orders to software sanctions. Worldspan to enter China in linkup with travel Web site
- Abstracts: Gucci's 1st-quarter profit comes in short of estimates. Hermes beats expectations with 38% increase in profit